Vitamin B3 study explores metabolism in sick patients
NCT ID NCT07156929
First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 29 times
Summary
This study gave 28 people with low tryptophan levels a special form of vitamin B3 (nicotinamide) for four weeks. Participants had either a serious respiratory infection (like pneumonia) or a chronic inflammatory condition (like inflammatory bowel disease). The goal was to measure how the body processes this vitamin, not to test a treatment. Patients could also report on their quality of life and fatigue.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASE (IBD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital Schleswig-Holstein, Campus Kiel
Kiel, Schleswig-Holstein, 24105, Germany
Conditions
Explore the condition pages connected to this study.